Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UCHL1 | P09936 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LIPE | Q05469 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
| ▸ | PLG | P00747 | 1/20 | 0.30 |
| ▸ | PLAU | P00749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4084426 | 0.80 | CA1 (0.47) | AAK1HIF1ADGAT1CA1CA2 | |
| SCHEMBL15774866 | 0.79 | UCHL1 (0.35) | UCHL1AAK1EGFRCA1CA2 | |
| SCHEMBL27171762 | 0.78 | MEN1 (0.36) | UCHL1EGFRCA1CA2CA9 | |
| SCHEMBL29424578 | 0.77 | CA2 (0.47) | UCHL1EGFRCA1CA2CA9 | |
| SCHEMBL5899720 | 0.77 | CA2 (0.47) | UCHL1EGFRCA1CA2CA9 | |
| SCHEMBL4106141 | 0.77 | LIPG (0.39) | EDNRBEDNRAAAK1HIF1ADGAT1 | |
| SCHEMBL30110892 | 0.76 | BRD4 (0.40) | KMT2A | |
| SCHEMBL3397535 | 0.74 | EDNRB (0.40) | EDNRBEDNRAAKR1C3AKR1C2KMT2A | |
| SCHEMBL14637225 | 0.74 | CA12 (0.54) | CA1CA2CA9 | |
| SCHEMBL15475652 | 0.74 | CA1 (0.38) | UCHL1NR1I2EGFRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8216856-B2 | Luminescent lanthanide labelling reagents and their use | ABACUS DIAGNOSTICA OY (FI) | 2012-07-10 | — | — | US | disclosed |
| EP-2052252-B1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | ABACUS DIAGNOSTICA OY (FI) | 2010-11-10 | — | — | EP | disclosed |
| US-20100081211-A1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | ABACUS DIAGNOSTICA OY (FI) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081211-A1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | SCLY, SRM, TST | UCHL1 2833/4885EDNRB 420/4885EDNRA 1139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.